NCT05687123 2026-03-18
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
National Cancer Institute (NCI)
Phase 1 Recruiting
Clinical Trials
3 trialsNCT00462553 2014-02-24
Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00397787 2013-06-04
Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine
National Cancer Institute (NCI)
Phase 2 Completed